Nov 9, 2021, 16:00 by

Brooks Automation has announced that its newly branded Azenta Life Sciences business has been contracted by QTC Management, Inc. to provide the storage and distribution of vaccines to the U.S. Department of Defense.

Nov 9, 2021, 16:00 by

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced with patient enrollment in the U.S.

Nov 9, 2021, 16:00 by

CDS’ eClinical platform, TrialKit, now offers sponsors and CROs the ability to create global registries in which the public can self-enroll and participate in studies from their mobile device

Nov 9, 2021, 16:00 by

Researchers will describe how they used a transporter-competent SCHH model to investigate the DDI potential of bempedoic acid, a drug indicated for hypercholesterolemia.

Nov 9, 2021, 16:00 by

MedExecWomen, an organization dedicated to empowering women in leadership roles in the medical device, diagnostics, drug delivery, and digital healthcare industries, hosted the second annual MedExecWomen conference on October 26, 2021, in Boston, MA.

Nov 3, 2021, 15:15 by User Not Found

Clinical Research News | ERT today announced that following its early Q2 merger with Bioclinica, the combined company is renamed Clario.

Nov 2, 2021, 01:00 by User Not Found

Clinical Research News | Medable’s big Series D, cryptographic data privacy, lung research, collaborative research and more.

Oct 29, 2021, 01:00 by User Not Found

Clinical Research News | THREAD expands to Europe, Middle East and Africa, TD2 adopts Medidata’s Rave CTMS, Genesis Research enhances its healthcare literature research platform, and RealTime Software improves digital signatures. Plus new products from Trialbee, Vivacare, AliveCor, and more.

Oct 27, 2021, 01:00 by User Not Found

Clinical Research News | Even as we make large strides toward the end of the pandemic, there is another growing global health crisis: antimicrobial resistance (AMR). The World Health Organization (WHO) calls AMR one of the top ten public health threats. There is an urgent need to focus on combating the health threat of AMR. The COVID-19 crisis, and the ensuing race to find treatments, has offered innovative and insightful approaches to implementing successful clinical trials related to infectious disease.

Oct 25, 2021, 01:00 by User Not Found

Clinical Research News | The Critical Path Institute (C-Path) recently debuted a first-of-its-kind Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) to encourage data-sharing and collaboration among investigators to accelerate treatment innovation for rare diseases. The ultimate value of the platform will be in getting drugs approved quicker.

Oct 20, 2021, 01:00 by User Not Found

Clinical Research News | The reporting of adverse events (AEs) in randomized controlled trials (RCTs) has only modestly improved over the past two decades. But more consistent inclusion of AEs in published studies will not, by itself, provide a balanced picture of the potential harms of interventions.

Oct 19, 2021, 01:00 by User Not Found

Clinical Research News | By the end of this year, consensus by a global coalition of researchers, healthcare providers, and patients on a core set of outcomes that should be included in all future studies of post-COVID syndrome—so-called “long COVID”—are expected to be publicly released. A core outcome set (COS) is urgently needed to optimize and standardize clinical data collection and reporting across clinical trials for the condition.

Oct 15, 2021, 16:50 by

Oct 15, 2021, 16:50 by

Sakura Finetek Europe has announced the appointment of Mr. Mateo Iglesias as Vice President of Marketing & Sales EMEAI.

Oct 15, 2021, 16:50 by

CluePoints, the premier provider of risk-based quality management (RBQM) and data oversight software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance oversight.  The new partnership pairs a best-in-breed solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with advanced capabilities in portfolio-level quality and operational oversight.

Oct 15, 2021, 16:50 by

Oct 15, 2021, 16:50 by

Oct 15, 2021, 16:50 by

Certara’s Simcyp COVID-19 Vaccine Model uses biosimulation to improve decision-making and help optimize dosing regimens of COVID-19 vaccines. Certara calibrated its model using the structure of actual COVID-19 vaccines and validated it by replicating the published clinical data. The model, which is incorporated in Certara’s Vaccine Simulator™, addresses important questions such as differences in response with age and ethnicity, optimal timing between doses and expected duration of antibody response.

Oct 15, 2021, 16:50 by

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has reported preclinical data that further supports the role of experimental anti-cancer drug, idronoxil, the active ingredient in Veyonda®, as an anti-inflammatory drug for early-stage COVID-19 treatments.

Oct 15, 2021, 01:00 by User Not Found

Clinical Research News | Traditionally designed clinical trials chronically struggle to enroll representative patient populations that will yield the comprehensive data needed to ensure that a new treatment will be safe and effective for everyone. I’ve been excited to watch decentralized clinical trial (DCT) approaches become more widely adopted because of their potential to democratize access to research. In order to produce the most accurate and reliable data about each new drug’s efficacy and safety, we have to meet participants and under-resourced sites where they are.